Penumbra
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Penumbra and other ETFs, options, and stocks.About PEN
Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system.
CEOAdam Elsesser
CEOAdam Elsesser
Employees4,500
Employees4,500
HeadquartersAlameda, California
HeadquartersAlameda, California
Founded2004
Founded2004
Employees4,500
Employees4,500
PEN Key Statistics
Market cap11.87B
Market cap11.87B
Price-Earnings ratio68.62
Price-Earnings ratio68.62
Dividend yield—
Dividend yield—
Average volume494.50K
Average volume494.50K
High today$304.00
High today$304.00
Low today$288.35
Low today$288.35
Open price$288.35
Open price$288.35
Volume550.76K
Volume550.76K
52 Week high$310.00
52 Week high$310.00
52 Week low$221.26
52 Week low$221.26
Stock Snapshot
Penumbra(PEN) stock is priced at $304.00, giving the company a market capitalization of 11.87B. It carries a P/E multiple of 68.62.
On 2025-12-10, Penumbra(PEN) stock traded between a low of $288.35 and a high of $304.00. Shares are currently priced at $304.00, which is +5.4% above the low and 0.0% below the high.
The Penumbra(PEN)'s current trading volume is 550.76K, compared to an average daily volume of 494.5K.
During the past year, Penumbra(PEN) stock moved between $221.26 at its lowest and $310.00 at its peak.
During the past year, Penumbra(PEN) stock moved between $221.26 at its lowest and $310.00 at its peak.
Analyst ratings
76%
of 21 ratingsBuy
76.2%
Hold
19%
Sell
4.8%
People also own
Based on the portfolios of people who own PEN. This list is generated using Robinhood data, and it’s not a recommendation.